Corporate venture capital teams face a critical bottleneck: manually assessing the IP portfolios of potential investment targets is slow, inconsistent, and risks missing key liabilities. This workflow automates that due diligence, ingesting target patent data, scientific publications, and product specs to generate a structured risk and opportunity assessment. It replaces weeks of manual review with hours of automated analysis, enabling faster deal flow and more informed capital allocation by quantifying IP defensibility and alignment with corporate strategic goals.




